Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Windlas Biotech Ltd
Industry : Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value(
)
543329
INE0H5O01029
215.4715093
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
WINDLAS
39.26
2338.43
EPS(TTM)
Face Value(
)
Div & Yield %:
28.5
5
0.49
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
630.96
513.08
465.93
427.60
328.85
288.20
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
630.96
513.08
465.93
427.60
328.85
288.20
Other Income
13.47
9.97
6.71
3.09
0.96
2.12
Stock Adjustments
-9.59
15.27
4.74
-3.67
12.75
-3.46
Total Income
634.84
538.32
477.38
427.02
342.56
286.86
EXPENDITURE :
Raw Materials
386.59
340.71
307.56
270.74
224.35
177.76
Power & Fuel Cost
16.15
12.90
11.01
11.53
8.04
6.22
Employee Cost
87.46
70.32
63.41
58.32
43.88
33.50
Other Manufacturing Expenses
10.52
8.63
8.95
8.37
4.28
3.61
Selling & Administrative Expenses
35.92
30.13
23.08
15.09
15.68
15.46
Miscellaneous Expenses
6.63
5.41
3.78
37.54
4.70
3.74
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
543.27
468.10
417.78
401.60
300.93
240.28
Operating Profit
91.57
70.21
59.60
25.44
41.63
46.59
Interest
1.10
0.79
1.42
1.29
2.37
3.64
Gross Profit
90.47
69.42
58.18
24.15
39.26
42.95
Depreciation
13.44
12.36
12.15
12.97
8.69
8.09
Profit Before Tax
77.03
57.06
46.03
11.18
30.57
34.86
Tax
17.34
14.35
10.13
4.84
8.24
12.58
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
1.54
0.06
-2.66
1.33
-0.13
-0.19
Reported Net Profit
58.14
42.64
38.56
5.01
22.46
22.47
Extraordinary Items
0.00
0.65
0.01
-14.49
0.00
0.35
Adjusted Net Profit
58.14
41.99
38.55
19.50
22.46
22.12
Adjustment below Net Profit
-0.24
-0.16
-0.18
-26.37
0.00
0.00
P & L Balance brought forward
176.70
141.84
103.46
124.82
98.49
76.02
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
8.32
7.63
0.00
0.00
0.00
0.00
P & L Balance carried down
226.29
176.70
141.84
103.46
120.95
98.49
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
110.00
80.00
70.00
0.00
0.00
0.00
Dividend Per Share(Rs)
5.50
4.00
3.50
0.00
0.00
0.00
Earnings Per Share-Unit Curr
27.96
20.38
17.69
7.81
35.03
35.05
Earnings Per Share(Adj)-Unit Curr
27.96
20.38
17.69
7.81
35.03
35.05
Book Value-Unit Curr
216.51
192.42
181.30
310.39
337.66
302.63
Book Value(Adj)-Unit Curr
216.51
192.42
181.30
310.39
337.66
302.63